EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

PTEN ‐mediated dephosphorylation of 53BP1 confers cellular resistance to DNA damage in cancer cells

Jianfeng He, Caihu Huang, Yanmin Guo, Rong Deng, Lian Li, Ran Chen, Yanli Wang, Jian Huang, Junke Zheng, Xian Zhao iD, Jianxiu Yu iD

Molecular Oncology · 2024-03 · 18 (3) · 580-605

DOI: 10.1002/1878-0261.13563 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Oncology, online erschienen am 12.12.2023. Verfasst von Jianfeng He und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Cell Biology, Shanghai Key Laboratory of Tumor Microenvironment and Inflammation, Shanghai Jiao Tong Univers…. Hauptthemen laut MEDLINE: Neoplasms, Tumor Suppressor Protein p14ARF. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China's National Key R&D Programmes, National Natural Science Foundation of China, Science and Technology Commission of Shanghai Municipality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Homologous recombination (HR) repair for DNA double‐strand breaks (DSBs) is critical for maintaining genome stability and conferring the resistance of tumor cells to chemotherapy. Nuclear PTEN which contains both phosphatidylinositol 3,4,5‐trisphosphate 3‐phosphatase and protein phosphatase plays a key role in HR repair, but the underlying mechanism remains largely elusive. We find that SUMOylated PTEN promotes HR repair but represses nonhomologous end joining (NHEJ) repair by directly dephosphorylating TP53‐binding protein 1 (53BP1). During DNA damage responses (DDR), tumor suppressor ARF (p14ARF) was phosphorylated and then interacted efficiently with PTEN, thus promoting PTEN SUMOylation as an atypical SUMO E3 ligase. Interestingly, SUMOylated PTEN was subsequently recruited to the chromatin at DSB sites. This was because SUMO1 that was conjugated to PTEN was recognized and bound by the SUMO‐interacting motif (SIM) of breast cancer type 1 susceptibility protein (BRCA1), which has been located to the core of 53BP1 foci on chromatin during S/G2 stage. Furthermore, these chromatin‐loaded PTEN directly and specifically dephosphorylated phosphothreonine‐543 (pT543) of 53BP1, resulting in the dissociation of the 53BP1 complex, which facilitated DNA end resection and ongoing HR repair. SUMOylation‐site‐mutated PTEN K254R mice also showed decreased DNA damage repair in vivo . Blocking the PTEN SUMOylation pathway with either a SUMOylation inhibitor or a p14ARF(2‐13) peptide sensitized tumor cells to chemotherapy. Our study therefore provides a new mechanistic understanding of PTEN in HR repair and clinical intervention of chemoresistant tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsTumor Suppressor Protein p14ARFAnimalsMiceBRCA1 ProteinChromatinDNADNA DamageDNA End-Joining RepairDNA RepairPTEN PhosphohydrolaseTumor Suppressor p53-Binding Protein 1

Stichwörter der Autor:innen

53BP1DNA damage repairPTENSUMOylationhomologous recombination (HR) repair

Substanzen

BRCA1 ProteinChromatinDNATumor Suppressor Protein p14ARFPten protein, mousePTEN PhosphohydrolaseTrp53bp1 protein, mouseTumor Suppressor p53-Binding Protein 1

Autor:innen und Institutionen

  • Department of Biochemistry and Molecular Cell Biology, Shanghai Key Laboratory of Tumor Microenvironment and Inflammation, Shanghai Jiao Tong University School of Medicine, China.
  • Department of Pathophysiology, Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education, Shanghai Jiao Tong University School of Medicine, China.

ORCID-Profile: Xian Zhao, Jianxiu Yu

Förderung

  • China's National Key R&D Programmes
  • National Natural Science Foundation of China
  • Science and Technology Commission of Shanghai Municipality

Zitieren

APA

He, J., Huang, C., Guo, Y., Deng, R., Li, L., Chen, R., Wang, Y., Huang, J., Zheng, J., Zhao, X., & Yu, J. (2024). PTEN ‐mediated dephosphorylation of 53BP1 confers cellular resistance to DNA damage in cancer cells. Molecular Oncology, 18(3), 580-605. https://doi.org/10.1002/1878-0261.13563

Vancouver

He J, Huang C, Guo Y, Deng R, Li L, Chen R, et al. PTEN ‐mediated dephosphorylation of 53BP1 confers cellular resistance to DNA damage in cancer cells. Molecular Oncology. 2024;18(3):580-605. doi:10.1002/1878-0261.13563

BibTeX
@article{He2024,
  author = {He, Jianfeng and Huang, Caihu and Guo, Yanmin and Deng, Rong and Li, Lian and Chen, Ran and Wang, Yanli and Huang, Jian and Zheng, Junke and Zhao, Xian and Yu, Jianxiu},
  title = {PTEN ‐mediated dephosphorylation of 53BP1 confers cellular resistance to DNA damage in cancer cells},
  journal = {Molecular Oncology},
  year = {2024},
  volume = {18},
  number = {3},
  pages = {580--605},
  doi = {10.1002/1878-0261.13563}
}
Kostenlos starten →